Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
General Infectious Disease
Do you recommend using topical metronidazole for managing odor related to pressure ulcers?
Do you have concerns about toxicity or antibiotic resistance with this approach?
Related Questions
Do you routinely perform echocardiography in patients with Staphylococcus aureus bacteremia deemed low risk for metastatic infection, or do you selectively omit it based on specific clinical criteria?
Do you routinely check cefepime levels in patient's with suspected cefepime-induced neurotoxicity?
Has your institution and/or antimicrobial stewardship program incorporated a selective antibiotic approach to treatment of left-sided uncomplicated diverticulitis in immunocompetent patients?
Do you routinely recommend a lumbar puncture for patients with suspected ocular or otic syphilis in the absence of additional CNS symptoms?
Is there a role for longer courses of antibiotic therapy for infections caused by Actinomyces neuii, similar to courses used for infections caused by other species of Actinomyces, now that it has been reclassified under the genus Winkia?
How do you approach treatment of tuberculous scleritis in pregnancy?
Do you choose an antibiotic with CSF penetration, such as nafcillin over cefazolin, in the setting of MSSA endocarditis with septic emboli to the brain (assuming no concomitant meningitis or brain abscess)?
What would be an ideal time to place a VP shunt in a patient with candida meningitis/ventriculitis?
Do you use combination therapy for persistent MSSA bacteremia?
Would you consider antifungal prophylaxis for immunocompromised patients with COVID-19 requiring mechanical ventilation, considering the high risk of invasive pulmonary aspergillosis in patients with severe COVID-19?